Effects of HMGB1/TLR4 on secretion IL-10 and VEGF in human jaw bone-marrow mesenchymal stem cells

J Appl Oral Sci. 2024 Feb 12:32:e20230304. doi: 10.1590/1678-7757-2023-0304. eCollection 2024.

Abstract

Objective: We aimed to investigate the regulatory effects of HMGB1/TLR4 signaling pathway on the expression of IL-10 and VEGF in human bone marrow mesenchymal stem cells.

Methodology: Human JBMSCs were isolated and cultured. Then, HMGB1 was added into the JBMSCs culture medium, and the protein and mRNA expression levels of IL-10 and VEGF were assessed. Moreover, cells were pretreated with a specific TLR4 inhibitor (TAK-242), and the expression changes of IL-10 and VEGF were compared.

Results: Compared with the control group, exposure to HMGB1 in human JBMSCs up-regulated TLR4, IL-10, and VEGF secretion at both protein and mRNA levels (P<0. 05). In addition, the increased expression of IL-10 and VEGF could be restrained in TAK-242 group compared with the HMGB1 group (P<0.05).

Conclusions: The results indicated that HMGB1 activate TLR4 signaling pathway in Human JBMSCs, which plays a regulatory role in cytokines expression.

MeSH terms

  • Bone Marrow / metabolism
  • HMGB1 Protein* / genetics
  • HMGB1 Protein* / metabolism
  • HMGB1 Protein* / pharmacology
  • Humans
  • Interleukin-10
  • Mesenchymal Stem Cells* / metabolism
  • RNA, Messenger
  • Sulfonamides*
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism
  • Vascular Endothelial Growth Factor A

Substances

  • ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate
  • Interleukin-10
  • Toll-Like Receptor 4
  • Vascular Endothelial Growth Factor A
  • HMGB1 Protein
  • RNA, Messenger
  • TLR4 protein, human
  • Sulfonamides